Strange Ventures writes the first check for deeply technical inventor-founders building the next frontier of computing, investing across the full stack from infrastructure to interfaces.
About Strange Ventures
Strange Ventures is an early-stage venture firm whose branding suggests a thesis around contrarian or non-consensus founders and businesses, often in frontier technology areas. Public detail on healthcare specificity, AI focus, and exact check size is limited from the inputs provided, but firms operating with this kind of positioning typically deploy seed and pre-seed checks in the range of one hundred thousand to one million dollars, often as a co-investor in a syndicate. Healthcare AI founders should approach only if the company has a genuinely differentiated angle that the firm’s contrarian framing would resonate with, rather than a conventional vertical SaaS or generalist healthcare software pitch. The natural fit is a technically ambitious team pursuing a thesis that mainstream investors are likely to dismiss or find too early, where the firm’s willingness to engage with non-consensus ideas creates an entry point. Founders pursuing standard healthcare enterprise sales motions or consumer wellness products will not find a strong fit. The platform value-add depends heavily on the specific principals and their network rather than a deep healthcare playbook, and founders should not expect clinical or regulatory coaching. The best entry path is a warm introduction from a contrarian founder or operator who has worked with the firm, or a referral from a fellow seed investor. Direct outreach via LinkedIn or the firm’s website is acceptable for cold contact, paired with a sharp articulation of why the company is non-consensus and what specifically makes the bet unusual.
Founder reviews
Other portfolio companies
Companies in Strange Ventures's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from Strange Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).